Reckitt, Abbott Shares Rise

Abbott and Reckitt unit secure win in infant formula trial
Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks.
Abbott, Reckitt Score First Victory in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.
Abbott jumps as jury says company, Reckitt not liable in infant formula case
Abbott Laboratories (NYSE:ABT) rose 6% in after hours trading after a jury found the company and a Reckitt Benckiser (OTCPK:RBGPF) unit are not liable over claims the companies' baby formula caused a potentially deadly illness. The jury reached the verdict ...
Reckitt limits sales decline amid baby formula lawsuits
The company, along with rival Abbott Laboratories, is defending more than 1,000 lawsuits that stand to potentially cost them both millions apiece.
Abbott, Reckitt Unit Defeat Claims in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby boy.
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas
A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not liable after a boy consumed the companies’ cow’s milk-based products for premature infants and became severely ill.
Abbott, Reckitt unit defeat claims in premature baby formula trial
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.
Bloomberg L.P.3d
Reckitt Surges Most in 24 Years After Baby Formula Trial Win
Shares of Reckitt Benckiser Group Plc jumped the most in 24 years following a US jury verdict that cleared it and Abbott ...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...
Reckitt (RKT) was downgraded to a Hold Rating at Bernstein
Bernstein analyst Callum Elliott downgraded Reckitt (RKT – Research Report) to a Hold today and set a price target of £53.00. The ...
Reckitt Benckiser's Revenue Expected to Drop on Lower Sales Volumes -- Earnings Preview
SALES FORECAST: The consumer-goods company--which houses Dettol, Harpic and Durex among its brands--is forecast to report a drop in quarterly revenue to 3.41 billion pounds ($4.43 billion) from 3.60 ...
FTSE 100 rebounds on Reckitt boost but logs weekly decline
The UK's FTSE 100 edged up on Friday from near three-month lows touched in the prior session, as gains in Reckitt Benckiser ...
Business Insider1d
Reckitt (RKT) Receives a Hold from Deutsche Bank
Deutsche Bank analyst Tom Sykes maintained a Hold rating on Reckitt (RKT – Research Report) today and set a price target of £50.00. The company’s shares opened today at p4,908.50. According to ...